TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
OMER

Omeros Corporation

Healthcare · Biotechnology

17.90$ -3.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement OMER
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
4,958.8% 7.7% 3.4% 1.7% 1.7% 2.4% 2.2% 1.5%
-4,858.8% 92.3% 96.6% 98.3% 98.3% 97.6% -2.2% -1.5%
8,895.4% 358.1% 121.8% 85.8% 300.9% 98.1% 145.8% 131.2%
4,193.1% 255.0% 103.6% 80.3% 164.8% 57.8% 98.5% 60.6%
13,088.5% 619.6% 227.0% 166.0% 474.0% 154.3% 210.4% 190.3%
-12,988.5% -527.3% -130.4% -67.7% -375.7% -56.7% -212.6% -191.8%
643.8% 26.4% 18.8% 17.0% 54.4% 20.3% 36.2% 21.7%
-13,668.5% -555.9% -160.4% -82.5% -467.7% -75.6% -266.1% -211.6%
544.9% 32.5% 20.3% 18.4% -43.3% 20.1% -31.5% -404.1%
-13,668.5% -555.9% -160.4% -82.5% -424.4% -75.6% -187.0% -123.1%
-12,964.2% -527.9% -140.9% -64.6% -410.0% -53.7% -227.6% -188.3%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?